ARA 290

Could It Offer a Solution? ARA-290 is an 11-amino acid linear peptide acting as an innate repair receptor (IRR) agonist. The IRR consists of the erythropoietin receptor and the beta-common (CD131) receptor, simultaneously triggering anti-inflammatory and tissue repair pathways.

Experimental evidence suggests that following peripheral nerve injury, the IRR becomes upregulated in the spinal cord, influencing the neurogenic inflammatory response.

Focusing on the innate repair receptor to address neuropathy: In studies, ARA290 has demonstrated efficacy in preclinical disease models, including neuropathy, without associated adverse effects. In these models, the peptide has been found to transform a pro-inflammatory, tissue-damaging environment into one that promotes healing and repair.

• Wound Healing
• Cardiovascular Health
• Neuropathic Pain Relief
• Anti-inflammatory Properties
• Improved Insulin Sensitivity
• Reduction in Chronic Fatigue
• Tissue Repair and Protection
• Improved Quality of Life in Sarcoidosis Patients

Common side effects are generally mild and may include localized reactions at the injection site. Consult with a healthcare provider for a complete list of potential side effects.

Individuals with known allergies to peptide medications or those with specific medical conditions that contraindicate its use should avoid ARA 290. Always consult a healthcare provider to ensure it’s appropriate for your health needs.